Atopic dermatitis — Dupriuzumab (Dapital)

• Safe and reliable: only approved for use by children and adults aged 6 months and above
• Precision targeting: Dual target targeting to prevent itching and skin lesions
• Remarkable efficacy: Skin lesions can be relieved by 70% after treatment, and it is also effective for moderate and severe asthma

Psoriasis: Secuchiumab (Coxantine)/Gusechiumab (Tenoya)

• Highly targeted: The target acts on inflammatory cytokines without harming other tissues
• Fast onset: arthritis patients can be injected on the same day to reduce swelling and pain, rash injection 2 times can be effective
• Short course of treatment: fewer injection times, less pain, low treatment time cost

Chronic urticaria: Omazumab (Challor ®)

• Managing symptoms: Patients with chronic spontaneous urticaria have a response rate of more than 90%
• Strong safety: the only targeted biologics with indications for asthma over 6 years of age
• Convenient treatment: only one injection per month

Vitiligo: Lucotinib cream

• A selective JAK1/JAK2 inhibitor with unique action
• Population: For the treatment of non-segmental vitiligo in adolescents and adults aged 12 years and older with facial involvement
• The curative effect has proven to be significant: after 24 weeks of topical treatment, the skin lesions showed significant recolor;
• With the extension of treatment time, the patient’s skin can continue to recolor.

Alopecia areata: Litxitinib toluene sulfonate (Levonol)

• Innovative drug: the world’s first and only drug for severe alopecia areata in both adolescents ≥12 years of age and adults
• Accurate efficacy: symptoms of severe alopecia areata were significantly improved at 24 weeks, and the curative effect lasted until 48 weeks, at which time 50% of adolescent patients had scalp hair coverage of 80% or above;
• Eyebrow regeneration improved in 67% of adolescents with severe alopecia areata, and eyelash regeneration improved in 73% of adolescents
• Long-term treatment was tolerated well, and most common adverse events were mild to moderate

Systemic lupus erythematosus: Afliumab

• Innovative and accurate: the world’s first and only treatment for lupus that targets the type I interferon pathway
• Curative effect: rapid relief can be achieved one week after use, two thirds of patients with glucocorticoid dose ≤5mg after four weeks, and one third achieved 0 hormone
• High safety: Adverse reactions are mainly mild or moderate, and can be relieved and resolved without stopping treatment

Diagnosis and Treatment of Skin, Hair and Nail Disorders, Such as:

• Acne
• Actinic keratosis
• Tiinea pedis
• Atopic dermatitis
• Bullous dermatosis
• Contact dermatitis (skin allergy)
• Eczema
• Hair loss
• Herpes
• Impetigo
• Keloid
• Lower limb ulcer
• Lice
• Lichen planus
• Melasma
• Mole
• Molluscum contagiosum
• Onychomycosis
• Perioral dermatitis
• Pityriasis rosea
• Bright red moles
• Post-inflammatory pigmentation
• Pruritus
• Psoriasis
• Rosacea
• Seborrheic dermatitis
• Seborrheic keratosis
• Skin cancer
• Skin infection
• Skin tag
• Sunburn
• Tinea versicolor
• Urticaria
• Hemangioma
• White epilepsy
• Wart

Sexually Transmitted Diseases

• Condyloma acuminatum
• Syphilis
• Gonorrhea
• Nongonococcal urethritis
• Genital herpes

Common Treatments Include:

• Cryotherapy: Removal of benign or precancerous skin lesions by freezing with liquid nitrogen
• Electrocautery: Use high-frequency electrical current to cauterize benign or precancerous skin lesions
• Minor surgery: surgical removal of diseased skin tissue
• Skin lesion biopsy: Obtaining small pieces of skin lesion tissue for deeper medical analysis, such as pathological examination
• UVB phototherapy: Treatment of skin conditions such as psoriasis, leukoplakia and alopecia by ultraviolet light.
• Laser: Treatment of various proliferative skin diseases, vascular diseases.
• Photodynamic therapy: Treatment of condyloma acuminatum, acne, rosacea, skin cancer and precancerous lesions, bright red nevus, etc.
• Facial treatment: acne, melasma, seborrheic dermatitis, flat warts, etc.

Skin Cancer Screening and Treatment

• Routine screening
• Medical science education for patients: skin protection and self-monitoring
• Skin cancer treatment: surgery, local treatment, etc